• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】41985

【品名】2-amino-3-nitrophenol

【CA登记号】603-85-0

【 分 子 式 】C6H6N2O3

【 分 子 量 】154.12532

【元素组成】C 46.76% H 3.92% N 18.18% O 31.14%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(I)

Alkylation of 2-amino-3-nitrophenol (I) with 1,2-dichloroethane in 2-butanone afforded the chloroethyl ether (II), which was further condensed with benzylamine (III) to give amine (IV) (1,2). Acylation of (IV) with trifluoroacetic anhydride provided trifluoroacetamide (V). The nitro group of (V) was then reduced by transfer hydrogenation using hydrazine and Pd/C. Cyclization of the resulting phenylenediamine (VI) in refluxing TFA gave rise to benzimidazole (VII). The trifluoroacetamido group of (VII) was finally removed by treatment with K2CO3 in boiling MeOH (1). In a more direct procedure, nitroaniline (IV) was reduced to diamine (VIII) and then cyclized to the title benzimidazole by treatment with TFA.

1 Brennan, J.A.; Coupet, J.; Mazandarani, H.; Andree, T.H.; Nelson, J.A.; Marquis, K.; Shi, X.; Shah, U.S.; Mewshaw, R.E.; New generation dopaminergic agents 7. heterocyclic bioisosteres that exploit the 3-OH-phenoxyethylamine D2 template. Bioorg Med Chem Lett 1999, 9, 17, 2593.
2 Nelson, J.A.; Mewshaw, R.E. (American Home Products Corp.); 4-Aminoalkoxy-1H-benzimidazole derivs., their preparation and their use as dopamine autoreceptor (D2) agonists. EP 0973749; WO 9835945 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 41985 2-amino-3-nitrophenol 603-85-0 C6H6N2O3 详情 详情
(II) 41986 2-(2-chloroethoxy)-6-nitrophenylamine; 2-(2-chloroethoxy)-6-nitroaniline C8H9ClN2O3 详情 详情
(III) 15147 Benzylamine; Phenylmethanamine 100-46-9 C7H9N 详情 详情
(IV) 41987 2-[2-(benzylamino)ethoxy]-6-nitroaniline; N-[2-(2-amino-3-nitrophenoxy)ethyl]-N-benzylamine C15H17N3O3 详情 详情
(V) 41988 N-[2-(2-amino-3-nitrophenoxy)ethyl]-N-benzyl-2,2,2-trifluoroacetamide C17H16F3N3O4 详情 详情
(VI) 41989 N-benzyl-N-[2-(2,3-diaminophenoxy)ethyl]-2,2,2-trifluoroacetamide C17H18F3N3O2 详情 详情
(VII) 41990 N-benzyl-2,2,2-trifluoro-N-(2-[[2-(trifluoromethyl)-1H-benzimidazol-4-yl]oxy]ethyl)acetamide C19H15F6N3O2 详情 详情
(VIII) 41991 2-amino-3-[2-(benzylamino)ethoxy]phenylamine; 3-[2-(benzylamino)ethoxy]-1,2-benzenediamine C15H19N3O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XXVI)

Sandmeyer reaction of 2-amino-3-nitrophenol (XXVI) using NaNO2 and HBr in the presence of CuBr in H2O/dioxane gives 2-bromo-3-nitrophenol (XXVII), which by O-alkylation with MeI in the presence of Cs2CO3 in DMF affords the methyl ether (XXVIII). Subsequent reduction of the nitro derivative (XXVIII) with Fe powder in refluxing AcOH/EtOH provides 2-bromo-3-methoxyaniline (XXIX) . Addition of aniline (XXIX) to dimethyl acetylene dicarboxylate (XXX) in refluxing MeOH produces the amino diester (XXXI), which by cyclization at 240 °C in diphenyl ether affords the quinoline (X) .

1 Llinas-Brunet, M., Bailey, M.D., Goudreau, N. et al. Discovery of a potent and selective noncovalent linear inhibitor of the hepatitis C virus NS3 protease (BI 201335). J Med Chem 2010, 53(17): 6466-76.
2 Llinas-Brunet, M., Bailey, M., Bhardwaj, P. et al. (Boehringer Ingelheim International GmbH & Co. KG). Hepatitis C inhibitor compounds. US 7585845.
3 Bhardwaj, P., Forgione, P., Goudreau, N. et al. (Boehringer Ingelheim International GmbH). Hepatitis C inhibitor compounds. EP 1654261, JP 2006528937, JP 2010043129, US 2005020503, US 2011177030, US 8067438, WO 2004103996.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(X) 68434 methyl 8-bromo-4-hydroxy-7-methoxyquinoline-2-carboxylate   C12H10BrNO4 详情 详情
(XXVI) 41985 2-amino-3-nitrophenol 603-85-0 C6H6N2O3 详情 详情
(XXVII) 68448 2-bromo-3-nitrophenol 101935-40-4 C6H4BrNO3 详情 详情
(XXVIII) 68449 2-bromo-1-methoxy-3-nitrobenzene;2-Bromo-3-nitroanisole 67853-37-6 C7H6BrNO3 详情 详情
(XXIX) 68451 2-bromo-3-methoxyaniline   C7H8BrNO 详情 详情
(XXX) 24551 Dimethyl acetylenedicarboxylate; Dimethyl 2-butynedioate;Acetylenedicarboxylic acid dimethyl ester 762-42-5 C6H6O4 详情 详情
(XXXI) 68450 dimethyl 2-((2-bromo-3-methoxyphenyl)amino)maleate   C13H14BrNO5 详情 详情
Extended Information